Aflatoxin B1 Up-Regulates Insulin Receptor Substrate 2 and Stimulates Hepatoma Cell Migration

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ma, Yanli ^a   Kong, Qingbin ^a   Hua, Hui ^a   Luo, Ting ^a   Jiang, Yangfu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEASOME; PROTEIN KINASE B; RECEPTOR BLOCKING AGENT; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL IMMORTALIZATION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

AFLATOXIN B1; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL MOVEMENT; HEP G2 CELLS; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; LIVER NEOPLASMS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 84868160006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047961     Document Type: Article

References (28)

1. Wild CP, Montesano R, (2009) A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett 286: 22-28.
2. Wild CP, Gong YY, (2010) Mycotoxins and human diseases: a largely ignored global health issue. Carcinogenesis 31: 71-82.
3. Kensler TW, Roebuck BD, Wogan GN, Groopman GD, (2011) Aflatoxin: a 50-Year odyssey of mechanistic andtranslational toxicology. Toxicol Sci 120(S1): S28-S48.
4. Ross RK, Yu MC, Henderson BE, Yuan JM, Qian JS, et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339: 943-946.
5. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, et al. (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98: 14601-14606.
6. Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, et al. (1997) Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev 6: 127-134.
7. Jubert C, Mata JE, Bench G, Dashwood R, Pereira C, et al. (2009) Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B1 pharmacokinetics in human volunteers. Cancer Prev Res 2: 1015-1022.
8. Ubagai T, Kikuchi T, Fukusato T, Ono Y, (2010) Aflatoxin B1 modulates the insulin-like growth factor-2 dependent sinaling axis. Toxicol in vitro 24: 783-789.
9. Lee YI, Lee S, Das GC, Park US, Park SM, et al. (2000) Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Oncogene 19: 3717-3726.
10. Gallagher EJ, LeRoith D, (2011) IGF, insulin, and cancer. Endocrinology 152: 2546-2551.
11. Samami AA, Yakar S, LeRoith D, et al. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47.
12. Scharf JG, Braulke T, (2003) The role of the IGF axis in hepatocarcinogenesis. Horm Metab Res 35: 685-693.
13. Kim SO, Park JG, Lee YI, (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res 56: 3831-3836.
14. Hussain SP, Schwank S, Staib F, Wang XW, Harris CC, (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26: 2166-2176.
15. Woo LL, Egner PA, Belanger CL, Wattanawaraporn R, Trudel LJ, et al. (2011) Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicol Sci 122: 38-44.
16. Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, et al. (2002) The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci USA 99: 6655-6660.
17. Paget V, Sichel F, Garon D, Lechevrel M, (2008) Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast). Mut Res 656: 55-61.
18. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186.
19. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904.
20. Nagle JA, Ma Z, Byrne MA, White MF, Shaw LM, (2004) Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 24: 9726-9735.
21. Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, et al. (2006) Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol 26: 9338-9351.
22. Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, et al. (2006) Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer 95: 1220-1228.
23. Hoang CD, Zhang X, Scott PD, Guillaume TJ, Maddaus MA, et al. (2004) Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes. Cancer Res 64: 7479-7485.
24. Kim B, van Golen CM, Feldman EL, (2004) Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene 23: 130-141.
25. Shaw LM, (2001) Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 21: 5082-5093.
26. Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, et al. (2006) Clinical significance of insulin receptor substrate-1 down-regulation in non-small cell lung cancer. Oncol Rep 16: 1205-1210.
27. Boissan M, Beurel E, Wendum D, Rey C, Lecluse Y, et al. (2005) Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am J Pathol. 167: 869-877.
28. Kelly VP, Ellis EM, Manson MM, Chanas SA, Moffat GJ, et al. (2000) Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarins a natural benzo(a)pyrene that is a potent inducer of AFB1-aldehyde reductase, the glutathioneS- transferase A5 and P1 sub units and NAD(P)H quinone oxidoreductase in rat liver. Cancer Res 60: 957-969.